Literature DB >> 23244636

Increased p22(phox)/Nox4 expression is involved in remodeling through hydrogen peroxide signaling in experimental persistent pulmonary hypertension of the newborn.

Stephen Wedgwood1, Satyan Lakshminrusimha, Lyubov Czech, Paul T Schumacker, Robin H Steinhorn.   

Abstract

AIM: To determine if the NADPH oxidase isoform Nox4 contributes to increased H(2)O(2) generation in persistent pulmonary hypertension of the newborn (PPHN) pulmonary arteries (PA), and to identify downstream signaling targets of Nox4 that contribute to vascular remodeling and vasoconstriction.
RESULTS: PPHN was induced in lambs by antenatal ligation of the ductus arteriosus at 128 days gestation. After 9 days, lungs, PA, and PA smooth muscle cells (PASMC) were isolated from control and PPHN lambs. Increased expression of p22(phox) and Nox4 in PPHN lungs, PA, and PASMC was associated with increased reactive oxygen species in PPHN PA, increased protein thiol oxidation in PPHN PASMC, and a decreased activity of extracellular superoxide dismutase (ecSOD) in the lungs and PASMC. Nox4 small interfering RNA (siRNA) decreased Nox4 expression and thiol oxidation and increased the ecSOD activity in PPHN PASMC. An increased activity of nuclear factor-kappa B (NFκB) and expression of its target gene cyclin D1 were detected in PPHN lungs, PA, and PASMC. Nox4 siRNA and catalase attenuated these increases in PASMC, and catalase decreased cyclin D1 expression in PPHN lungs. INNOVATION: This study demonstrates for the first time that Nox4 expression is elevated in a lamb model of neonatal pulmonary hypertension. It identifies increased NFκB and cyclin D1 expression and a decreased ecSOD activity as targets of increased Nox4 signaling.
CONCLUSION: PPHN increases p22(phox) and Nox4 expression and activity resulting in elevated H(2)O(2) levels in PPHN PA. Increased H(2)O(2) induces vasoconstriction via mechanisms involving ecSOD inactivation, and stimulates vascular remodeling via NFκB activation and increased cyclin D1 expression. Approaches that inhibit the pulmonary arterial Nox4 activity may attenuate vasoconstriction and vascular remodeling in PPHN.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23244636      PMCID: PMC3619152          DOI: 10.1089/ars.2012.4766

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  50 in total

1.  NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.

Authors:  D C Guttridge; C Albanese; J Y Reuther; R G Pestell; A S Baldwin
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

Review 2.  Extracellular superoxide dismutase.

Authors:  Eva Nozik-Grayck; Hagir B Suliman; Claude A Piantadosi
Journal:  Int J Biochem Cell Biol       Date:  2005-07-21       Impact factor: 5.085

3.  Pulmonary endothelial NO synthase gene expression is decreased in fetal lambs with pulmonary hypertension.

Authors:  P W Shaul; I S Yuhanna; Z German; Z Chen; R H Steinhorn; F C Morin
Journal:  Am J Physiol       Date:  1997-05

Review 4.  NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease.

Authors:  Hua Cai
Journal:  Circ Res       Date:  2005-04-29       Impact factor: 17.367

5.  Increased hydrogen peroxide downregulates soluble guanylate cyclase in the lungs of lambs with persistent pulmonary hypertension of the newborn.

Authors:  Stephen Wedgwood; Robin H Steinhorn; Melisa Bunderson; Jason Wilham; Satyan Lakshminrusimha; Lisa A Brennan; Stephen M Black
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-06-03       Impact factor: 5.464

6.  Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor-mediated generation of hydrogen peroxide.

Authors:  Stephen Wedgwood; Stephen M Black
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-11-05       Impact factor: 5.464

7.  Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension.

Authors:  Satyan Lakshminrusimha; James A Russell; Stephen Wedgwood; Sylvia F Gugino; Jeffrey A Kazzaz; Jonathan M Davis; Robin H Steinhorn
Journal:  Am J Respir Crit Care Med       Date:  2006-09-28       Impact factor: 21.405

8.  Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway.

Authors:  D Joyce; B Bouzahzah; M Fu; C Albanese; M D'Amico; J Steer; J U Klein; R J Lee; J E Segall; J K Westwick; C J Der; R G Pestell
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

9.  NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation.

Authors:  Lena Serrander; Laetitia Cartier; Karen Bedard; Botond Banfi; Bernard Lardy; Olivier Plastre; Andrzej Sienkiewicz; Lászlo Fórró; Werner Schlegel; Karl-Heinz Krause
Journal:  Biochem J       Date:  2007-08-15       Impact factor: 3.857

10.  A nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats.

Authors:  Hirofumi Sawada; Yoshihide Mitani; Junko Maruyama; Bao Hua Jiang; Yukiko Ikeyama; Francis A Dida; Hatsumi Yamamoto; Kyoko Imanaka-Yoshida; Hideto Shimpo; Akira Mizoguchi; Kazuo Maruyama; Yoshihiro Komada
Journal:  Chest       Date:  2007-10       Impact factor: 9.410

View more
  29 in total

Review 1.  Cellular Pathways Promoting Pulmonary Vascular Remodeling by Hypoxia.

Authors:  Larissa A Shimoda
Journal:  Physiology (Bethesda)       Date:  2020-07-01

2.  Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension.

Authors:  Feng Chen; Xueyi Li; Emily Aquadro; Stephen Haigh; Jiliang Zhou; David W Stepp; Neal L Weintraub; Scott A Barman; David J R Fulton
Journal:  Free Radic Biol Med       Date:  2016-08-03       Impact factor: 7.376

Review 3.  Role of reactive oxygen species in neonatal pulmonary vascular disease.

Authors:  Stephen Wedgwood; Robin H Steinhorn
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

4.  Hypoxia inhibits expression and function of mitochondrial thioredoxin 2 to promote pulmonary hypertension.

Authors:  Sherry E Adesina; Brandy E Wade; Kaiser M Bijli; Bum-Yong Kang; Clintoria R Williams; Jing Ma; Young-Mi Go; C Michael Hart; Roy L Sutliff
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-01-27       Impact factor: 5.464

5.  Targeting mitochondrial reactive oxygen species to modulate hypoxia-induced pulmonary hypertension.

Authors:  Sherry E Adesina; Bum-Yong Kang; Kaiser M Bijli; Jing Ma; Juan Cheng; Tamara C Murphy; C Michael Hart; Roy L Sutliff
Journal:  Free Radic Biol Med       Date:  2015-06-12       Impact factor: 7.376

6.  Thiol-Redox Regulation in Lung Development and Vascular Remodeling.

Authors:  Gaston Ofman; Trent E Tipple
Journal:  Antioxid Redox Signal       Date:  2019-03-04       Impact factor: 8.401

Review 7.  Responses to reductive stress in the cardiovascular system.

Authors:  Diane E Handy; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2016-12-08       Impact factor: 7.376

8.  Nogo-B Receptor Modulates Pulmonary Artery Smooth Muscle Cell Function in Developing Lungs.

Authors:  Kent S Tadokoro; Ujala Rana; Xigang Jing; G Ganesh Konduri; Qing R Miao; Ru-Jeng Teng
Journal:  Am J Respir Cell Mol Biol       Date:  2016-06       Impact factor: 6.914

Review 9.  Endothelial and Smooth Muscle Cell Interactions in the Pathobiology of Pulmonary Hypertension.

Authors:  Yuansheng Gao; Tianji Chen; J Usha Raj
Journal:  Am J Respir Cell Mol Biol       Date:  2016-04       Impact factor: 6.914

10.  Antioxidant therapy for the treatment of pulmonary hypertension.

Authors:  Yuichiro J Suzuki; Robin H Steinhorn; Mark T Gladwin
Journal:  Antioxid Redox Signal       Date:  2013-02-28       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.